4.5 Article

A novel recurrent mutation in ATP1A3 causes CAPOS syndrome

期刊

出版社

BIOMED CENTRAL LTD
DOI: 10.1186/1750-1172-9-15

关键词

CAPOS syndrome; Cerebellar ataxia; Optic atrophy; Sensorineural hearing loss; ATP1A3

资金

  1. Genome Canada
  2. Genome British Columbia through the FORGE Canada Consortium
  3. British Columbia Clinical Genomics Network
  4. Michael Smith Foundation for Health Research
  5. Rare Disease Foundation
  6. Omics2TreatID
  7. Canadian Institutes of Health Research

向作者/读者索取更多资源

Background: We undertook genetic analysis of three affected families to identify the cause of dominantly-inherited CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorineural hearing loss) syndrome. Methods: We used whole-exome sequencing to analyze two families affected with CAPOS syndrome, including the original family reported in 1996, and Sanger sequencing to assess familial segregation of rare variants identified in the probands and in a third, apparently unrelated family with CAPOS syndrome. Results: We found an identical heterozygous missense mutation, c.2452G>A (p.(Glu818Lys)), in the Na+/K+ ATPase alpha(3) (ATP1A3) gene in the proband and his affected sister and mother, but not in either unaffected maternal grandparent, in the first family. The same mutation was also identified in the proband and three other affected members of the second family and in all three affected members of the third family. This mutation was not found in more than 3600 chromosomes from unaffected individuals. Conclusion: Other mutations in ATP1A3 have previously been demonstrated to cause rapid-onset dystonia-parkinsonism (also called dystonia- 12) or alternating hemiplegia of childhood. This study shows that an allelic mutation in ATP1A3 produces CAPOS syndrome.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Health Care Sciences & Services

Utilization of telehealth in paediatric genome-wide sequencing: Health services implementation issues in the CAUSES Study

Alison M. Elliott, Nick Dragojlovic, Teresa Campbell, Shelin Adam, Christele du Souich, Michele Fryer, Anna Lehman, Clara van Karnebeek, Larry D. Lynd, Jan M. Friedman

Summary: Genome-wide sequencing is revolutionizing the care of pediatric patients with rare diseases, with genetic counselling recommended for families undergoing this procedure. Telehealth has enabled access to genome-wide sequencing for families in remote areas, but has led to delays in sample accrual.

JOURNAL OF TELEMEDICINE AND TELECARE (2023)

Article Biotechnology & Applied Microbiology

NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma

Rahul Arora, Logan Haynes, Mehul Kumar, Reid McNeil, Jahanshah Ashkani, Steven C. Nakoneshny, T. Wayne Matthews, Shamir Chandarana, Robert D. Hart, Steven J. M. Jones, Joseph C. Dort, Doha Itani, Ayan Chanda, Pinaki Bose

Summary: There is a lack of prognostic biomarkers and targeted therapeutics for oral squamous cell carcinoma (OSCC). However, amplification of the chromosomal segment 3q22-3q29 is observed in many epithelial cancers, including OSCC. Through an integrative analysis, we identified NCBP2 and TFRC as potential prognostic biomarkers for HPV-negative OSCC, and showed that NCBP2 depletion can inhibit OSCC cell proliferation, migration, and invasion.

CANCER GENE THERAPY (2023)

Article Genetics & Heredity

Finding the sweet spot: a qualitative study exploring patients' acceptability of chatbots in genetic service delivery

Stephanie Luca, Marc Clausen, Angela Shaw, Whiwon Lee, Suvetha Krishnapillai, Ella Adi-Wauran, Hanna R. Faghfoury, Gregory Costain, Rebekah Jobling, Melyssa Aronson, Eriskay Liston, Josh Silver, Cheryl Shuman, Lauren Chad, Robin Hayeems, Yvonne J. Bombard, Genetics Navigator Study Team

Summary: This study investigated the preferences of individuals who underwent genetic testing for using chatbots. It found that chatbots were considered inefficient for very simple and very complex tasks, but acceptable for moderately complex tasks. Participants also expressed the need for a safety net (access to a clinician) for unaddressed needs. These findings can inform the implementation of chatbots in genomic medicine.

HUMAN GENETICS (2023)

Editorial Material Developmental Biology

Bob Brent: Medical expert, expert medical witness, and expert on medical expert witnessing

Jan M. Friedman

BIRTH DEFECTS RESEARCH (2023)

Article Biochemistry & Molecular Biology

Defining the heterogeneity of unbalanced structural variation underlying breast cancer susceptibility by nanopore genome sequencing

Katherine Dixon, Yaoqing Shen, Kieran O'Neill, Karen L. L. Mungall, Simon Chan, Steve Bilobram, Wei Zhang, Marjorie Bezeau, Alshanee Sharma, Alexandra Fok, Andrew J. J. Mungall, Richard Moore, Ian Bosdet, My Linh Thibodeau, Sophie Sun, Stephen Yip, Kasmintan A. A. Schrader, Steven J. M. Jones

Summary: Nanopore long-read sequencing accurately detects pathogenic copy number alterations in cancer susceptibility genes and reveals unforeseen allelic heterogeneity and mechanisms of recurrent deletions. Integrating read-based and statistical phasing helps define extended haplotypes associated with founder alleles. Long-read sequencing is a sensitive method for characterizing private, recurrent and founder structural variants underlying breast cancer susceptibility.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Editorial Material Genetics & Heredity

Contemplating syndromic autism

Jacob A. S. Vorstman, Stephen W. Scherer

GENETICS IN MEDICINE (2023)

Article Genetics & Heredity

Great expectations: patients' preferences for clinically significant results from genomic sequencing

Salma Shickh, Agnes H. Sebastian, Marc Clausen, Chloe Mighton, Christine F. Elser, Andrea Eisen, Larissa Waldman, Seema Panchal, Thomas Ward, June E. Carroll, Emily Glogowski, Kasmintan Schrader, Jordan A. Lerner-Ellis, Raymond Kim, Kevin E. Thorpe, Yvonne Bombard

Summary: This study aimed to understand patient preferences and factors influencing preferences for secondary findings from genomic sequencing. The majority of adult cancer patients in the trial expressed interest in receiving various types of secondary findings, even those without immediate medical actionability. Older participants were more interested in early-onset neurological diseases, and those with lower decisional conflict were more likely to select all categories. The results emphasize the importance of incorporating patient preferences into guidelines on secondary findings.

HUMAN GENETICS (2023)

Article Biochemistry & Molecular Biology

ANK2 loss-of-function variants are associated with epilepsy, and lead to impaired axon initial segment plasticity and hyperactive network activity in hiPSC-derived neuronal networks

Maria W. A. Teunissen, Elly Lewerissa, Eline J. H. van Hugte, Shan Wang, Charlotte W. Ockeloen, David A. Koolen, Rolph Pfundt, Carlo L. M. Marcelis, Eva Brilstra, Jennifer L. Howe, Stephen W. Scherer, Xavier Le Guillou, Frederic Bilan, Michelle Primiano, Jasmin Roohi, Amelie Piton, Anne de Saint Martin, Sarah Baer, Simone Seiffert, Konrad Platzer, Rami Abou Jamra, Steffen Syrbe, Jan H. Doering, Shenela Lakhani, Srishti Nangia, Christian Gilissen, R. Jeroen Vermeulen, Rob P. W. Rouhl, Han G. Brunner, Marjolein H. Willemsen, Nael Nadif Kasri

Summary: This study aimed to characterize a new neurodevelopmental syndrome caused by loss-of-function variants in ANK2 gene and explore the effects on neuronal network dynamics and homeostatic plasticity in human induced pluripotent stem cell-derived neurons. Clinical and molecular data of 12 individuals with heterozygous de novo loss-of-function variants in ANK2 were collected. HiPSCs with a heterozygous loss-of-function allele of ANK2 were generated using CRISPR/Cas9. Excitatory neurons were differentiated from these hiPSCs and their spontaneous electrophysiological responses were measured using micro-electrode arrays. Results showed a broad neurodevelopmental disorder with intellectual disability, autism spectrum disorders, and early onset epilepsy. HiPSC-derived neurons with ANK2 loss-of-function exhibited a hyperactive and desynchronized neuronal network, increased somatodendritic structures, and altered AIS structure with impaired activity-dependent plasticity.

HUMAN MOLECULAR GENETICS (2023)

Article Biochemistry & Molecular Biology

Gene copy number variation and pediatric mental health/neurodevelopment in a general population

Mehdi Zarrei, Christie L. Burton, Worrawat Engchuan, Edward J. Higginbotham, John Wei, Sabah Shaikh, Nicole M. Roslin, Jeffrey R. MacDonald, Giovanna Pellecchia, Thomas Nalpathamkalam, Sylvia Lamoureux, Roozbeh Manshaei, Jennifer Howe, Brett Trost, Bhooma Thiruvahindrapuram, Christian R. Marshall, Ryan K. C. Yuen, Richard F. Wintle, Lisa J. Strug, Dimitri J. Stavropoulos, Jacob A. S. Vorstman, Paul Arnold, Daniele Merico, Marc Woodbury-Smith, Jennifer Crosbie, Russell J. Schachar, Stephen W. Scherer

Summary: In a Canadian community sample of 7100 unrelated children and youth of European or East Asian ancestry, we found that gene copy number variation (CNV) is associated with mental health/neurodevelopmental traits and diagnoses, physical health, and cognition. Clinically significant or susceptibility CNVs were present in 3.9% of participants and were associated with elevated scores on attention-deficit/hyperactivity disorder (ADHD) traits, longer response inhibition, and increased prevalence of mental health diagnoses, specifically ADHD, autism spectrum disorder, anxiety, and learning problems/learning disorder. Our data also revealed an increased burden of rare deletions in gene-sets related to brain function associated with more ADHD traits. This study provides valuable insights into the genetic contributions to pediatric-onset conditions, especially in the current mental health crisis.

HUMAN MOLECULAR GENETICS (2023)

Article Biochemistry & Molecular Biology

Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study

E. Titmuss, K. Milne, M. R. Jones, T. Ng, J. T. Topham, S. D. Brown, D. F. Schaeffer, S. Kalloger, D. Wilson, R. D. Corbett, L. M. Williamson, K. Mungall, A. J. Mungall, R. A. Holt, B. H. Nelson, S. J. M. Jones, J. Laskin, H. J. Lim, M. A. Marra

Summary: The POG program at BC Cancer identified specific alterations in colorectal cancer using whole genome and transcriptome analysis, and successfully treated a patient with irbesartan, an antihypertensive drug, resulting in a profound and durable response. Analysis showed an increase in immune signaling and infiltrating immune cells, particularly CD8+ T cells, in the relapsed tumor, suggesting an activated immune response contributed to the anti-tumor effect.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Immunology

Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease

Mehul Sharma, Daniel Leung, Mana Momenilandi, Lauren C. W. Jones, Lucia Pacillo, Alyssa E. James, Jill R. Murrell, Selket Delafontaine, Jesmeen Maimaris, Maryam Vaseghi-Shanjani, Kate L. Del Bel, Henry Y. Lu, Gilbert T. Chua, Silvia Di Cesare, Oriol Fornes, Zhongyi Liu, Gigliola Di Matteo, Maggie P. Fu, Donato Amodio, Issan Yee San Tam, Gavin Shueng Wai Chan, Ashish A. Sharma, Joshua Dalmann, Robin van der Lee, Geraldine Blanchard-Rohner, Susan Lin, Quentin Philippot, Phillip A. Richmond, Jessica J. Lee, Allison Matthews, Michael Seear, Alexandra K. Turvey, Rachael L. Philips, Terri F. Brown-Whitehorn, Christopher J. Gray, Kosuke Izumi, James R. Treat, Kathleen H. Wood, Justin Lack, Asya Khleborodova, Julie E. Niemela, Xingtian Yang, Rui Liang, Lin Kui, Christina Sze Man Wong, Grace Wing Kit Poon, Alexander Hoischen, Caspar I. van der Made, Jing Yang, Koon Wing Chan, Jaime Sou Da Rosa Duque, Pamela Pui Wah Lee, Marco Hok Kung Ho, Brian Hon Yin Chung, Huong Thi Minh Le, Wanling Yang, Pejman Rohani, Ali Fouladvand, Hassan Rokni-Zadeh, Majid Changi-Ashtiani, Mohammad Miryounesi, Anne Puel, Mohammad Shahrooei, Andrea Finocchi, Paolo Rossi, Beatrice Rivalta, Cristina Cifaldi, Antonio Novelli, Chiara Passarelli, Stefania Arasi, Dominique Bullens, Kate Sauer, Tania Claeys, Catherine M. Biggs, Emma C. Morris, Sergio D. Rosenzweig, John J. O'Shea, Wyeth W. Wasserman, H. Melanie Bedford, Clara D. M. van Karnebeek, Paolo Palma, Siobhan O. Burns, Isabelle Meyts, Jean-Laurent Casanova, Jonathan J. Lyons, Nima Parvaneh, Anh Thi Van Nguyen, Caterina Cancrini, Jennifer Heimall, Hanan Ahmed, Margaret L. McKinnon, Yu Lung Lau, Vivien Beziat, Stuart E. Turvey

Summary: Sharma et al. define a new primary atopic disorder caused by heterozygous gain-of-function variants in STAT6. This leads to severe early-onset allergies in 16 patients from 10 families. Treatment with anti-IL-4Rα antibody and JAK inhibitor is highly effective.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Review Genetics & Heredity

A model for the return and referral of all clinically significant secondary findings of genomic sequencing

Rita Kodida, Emma Reble, Marc Clausen, Salma Shickh, Chloe Mighton, Jordan Sam, Nicole Forster, Seema Panchal, Melyssa Aronson, Kara Semotiuk, Tracy Graham, Yael Silberman, Susan Randall Armel, Jeanna M. McCuaig, Iris Cohn, Chantal F. Morel, Christine Elser, Andrea Eisen, June C. Carroll, Emily Glogowski, Kasmintan A. Schrader, Vanessa Di Gioacchino, Jordan Lerner-Ellis, Raymond H. Kim, Yvonne Bombard, Incidental Genom Study Team

Summary: Secondary findings identified through genomic sequencing can provide various health benefits to patients, but resource and capacity constraints pose challenges to their clinical management. Clinical workflows are needed to optimize the benefits of these findings.

JOURNAL OF MEDICAL GENETICS (2023)

Article Oncology

Mitogen-induced defective mitosis transforms neural progenitor cells

Hiba K. Omairi, Cameron J. Grisdale, Mathieu Meode, Alexandra K. Bohm, Sophie Black, Nancy J. Adam, Cassidy P. Chapman, Tatiana Maroilley, John J. Kelly, Maja Tarailo-Graovac, Steven J. M. Jones, Michael D. Blough, John Gregory Cairncross

Summary: This study reveals that PDGFA fails to induce the expression of kinetochore and spindle assembly checkpoint genes, leading to defective mitosis in neural progenitor cells (NPCs). Surviving cells with unstable genomes accumulate chromosomal rearrangements and give rise to tumorigenic NPCs with recurrent gains and losses of chromosomal regions. This work provides new insights into the mechanisms underlying the development of glioblastoma.

NEURO-ONCOLOGY (2023)

Article Clinical Neurology

Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS): an international, multicentre, pilot cohort study

Alissa M. D'Gama, Sarah Mulhern, Beth R. Sheidley, Fadil Boodhoo, Sarah Buts, Natalie J. Chandler, Joanna Cobb, Meredith Curtis, Edwardj Higginbotham, Jonathon Holland, Tayyaba Khan, Julia Koh, Nicole S. Yliang, Lyndsey Mcrae, Sarah E. Nesbitt, Brandon T. Oby, Ben Paternoster, Alistair Patton, Graham Rose, Elizabeth Scotchman, Rozalia Valentine, Kimberly N. Wiltrout, Robin Z. Hayeems, Puneet Jain, Sebastian Lunke, Christian R. Marshall, Shira Rockowitz, Neilj Sebire, Zornitza Stark, Susan M. White, Lyn S. Chitty, J. Helen Cross, Ingrid E. Scheffer, Vann Chau, Gregory Costain, Annapurna Poduri, Katherine B. Howell, Amy McTague

Summary: A cohort study was conducted to determine the feasibility and clinical utility of rapid genome sequencing in infants with new-onset epilepsy. Among 100 infants enrolled in the study, genetic diagnoses were identified in 43% of the cases. Rapid genome sequencing had immediate clinical impact on treatment, evaluation, prognosis, and recurrence risk counselling.

LANCET NEUROLOGY (2023)

Correction Genetics & Heredity

A mutational hotspot in AMOTL1 defines a new syndrome of orofacial clefting, cardiac anomalies, and tall stature (vol 191A, 1227, 2023)

Alanna Strong, Soumya Rao, Sandra von Hardenberg, Dong Li, Liza L. Cox, Paul C. Lee, Li Q. Zhang, Waheed Awotoye, Tamir Diamond, Jessica Gold, Catherine Gooch, Lord Jephthah Joojo Gowans, Hakon Hakonarson, Anne Hing, Kathleen Loomes, Nicole Martin, Thanuja Selvanayagam, Mary L. Marazita, Tarja Mononen, David Piccoli, Rolph Pfundt, Salmo Raskin, Stephen W. Scherer, Nara Sobriera, Courtney Vaccaro, Xiang Wang, Deborah Watson, Rosanna Weksberg, Elizabeth Bhoj, Jeffrey C. Murray, Andrew C. Lidral, Azeez Butali, Michael F. Buckley, Tony Roscioli, David A. Koolen, Laurie H. Seaver, Cynthia A. Prows, Rolf W. Stottmann, Timothy C. Cox

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2023)

暂无数据